There’s a reason why Medicare Advantage is fertile ground for fraud enforcement.
Tag: group
When Teenagers Mix $15 Creams Sold for $16,000: A Lesson in Arrogance, Greed—and Consequences
Imagine a pharmacy operation so brazen that it paid doctors millions in kickbacks to prescribe compound creams mixed in the backroom by untrained teenagers—then billed the government as much as $16,000 per tube.
Don’t Be the Next Headline: What a $405 Million Pharmacy Fraud Case Should Teach Physicians
Why doctors must prioritize compliance—and legal advice—before signing anything.
An Algorithmic Conspiracy? DOJ Weighs In on MultiPlan Case
As healthcare payers, tech platforms, and pricing vendors increasingly collaborate through sophisticated analytics, this case is a clear reminder: if you’re coordinating decisions that competitors used to make…
Advanced Practice Providers Aren’t Necessarily the Grout For the Physician Gap
Supervisory requirements aren’t just administrative niceties; they’re the difference between compliant practice and a lawsuit waiting to happen.
BOI: The Latest
On March 21, 2025, the Treasury Department’s Financial Crimes Enforcement Network (“FinCEN”), the agency charged with enforcing the CTA, issued a new interim final rule removing the requirement for U.S. companies and U.S. persons to report beneficial ownership information under the Corporate Transparency Act.
Medical Group Growth Without Recruiting
It’s not news to you that there’s a huge shortage of physicians in many medical specialties, such as in anesthesiology and radiology. With the overall aging of the physician population, shortages in other medical specialties, including those that are office-based, will intensify.
Have You Mistakenly Sold Out Your Future for Stipend Support?
Even in the face of the provider shortage, during which you think that you have substantial negotiating leverage, when a significant chunk of your revenue comes from the hospital, you’re no longer just a contractor. You’re an appendage.
BOI Rollercoaster: Government Pauses Enforcement of BOI Filing Deadlines
FinCEN states that it will issue a new interim final rule by March 21st that extends BOI reporting deadlines, provides new guidance and clarity, and reduces the regulatory burden.
BOI oh BOI: Reporting Under the Corporate Transparency Act is Back On . . . Sort Of
Is the government hard of hearing? Business likes certainty. Apparently, the government heard that as business likes uncertainty. So, although, as I’ll mention in a moment, mandatory BOI reporting under the Corporate Transparency Act is now back on, it might not be for long. The immediately prior nationwide injunction against mandatory BOI reporting, in place…